Cargando…
The ‘false hope’ argument in discussions on expanded access to investigational drugs: a critical assessment
When seriously ill patients reach the end of the standard treatment trajectory for their condition, they may qualify for the use of unapproved, investigational drugs regulated via expanded access programs. In medical-ethical discourse, it is often argued that expanded access to investigational drugs...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer Netherlands
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9366814/ https://www.ncbi.nlm.nih.gov/pubmed/35951276 http://dx.doi.org/10.1007/s11019-022-10106-y |